Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation
Yaohua Zhang,Zilong Zhao,Lisa A Huang,Yuan Liu,Jun Yao,Chengcao Sun,Yajuan Li,Zhao Zhang,Youqiong Ye,Fei Yuan,Tina K Nguyen,Nikhil Reddy Garlapati,Andrew Wu,Sergey D Egranov,Abigail S Caudle,Aysegul A Sahin,Bora Lim,Laura Beretta,George A Calin,Dihua Yu,Mien-Chie Hung,Michael A Curran,Katayoun Rezvani,Boyi Gan,Zhi Tan,Leng Han,Chunru Lin,Liuqing Yang
DOI: https://doi.org/10.1016/j.cmet.2023.05.009
2023-08-08
Abstract:Obesity, in which the functional importance of small nucleolar RNAs (snoRNAs) remains elusive, correlates with risk for many cancer types. Here, we identify that the serum copies of adipocyte-expressed SNORD46 correlate with body mass index (BMI), and serum SNORD46 antagonizes interleukin-15 (IL-15) signaling. Mechanically, SNORD46 binds IL-15 via G11, and G11A (a mutation that significantly enhances binding affinity) knockin drives obesity in mice. Functionally, SNORD46 blocks IL-15-induced, FER kinase-dependent phosphorylation of platelet glycoprotein 4 (CD36) and monoglyceride lipase (MGLL) in adipocytes, leading to inhibited lipolysis and browning. In natural killer (NK) cells, SNORD46 suppresses the IL-15-dependent autophagy, leading to reduced viability of obese NK. SNORD46 power inhibitors exhibit anti-obesity effects, concurring with improved viability of obese NK and anti-tumor immunity of CAR-NK cell therapy. Hence, our findings demonstrate the functional importance of snoRNAs in obesity and the utility of snoRNA power inhibitors for antagonizing obesity-associated immune resistance.